SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Zhangmen Education Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

THE ANGEL–(BUSINESS WIRE) – Schall Law Firm, a national shareholder law firm, has announced that it will be filing a class action lawsuit against Zhangmen Education Inc. (“Zhangmen” or “the Company”) (NYSE: ZME) for violating federal securities laws.

Investors who have acquired and / or are attributable to the Company’s shares following the Company’s initial public offering on June 8, 2021 (the “IPO”) are advised to contact the Company prior to January 18, 2022 .

If you are a shareholder who has suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall law firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335 to discuss your rights free of charge. You can also contact us on the firm’s website at www.schallfirm.com or by email at brian@schallfirm.com.

In this case, the class has not yet been certified and you will not be represented by a lawyer until certified. If you do nothing, you can remain an absent class member.

According to the lawsuit, the company provided false and misleading information to the market. Zhangmen was the subject of large-scale reform of the private education market by the Chinese government, which included a ban on the pursuit of profit and the raising of capital. The known risks and uncertainties are likely to have a materially negative impact on the company’s future prospects. As a result of these facts, the company’s public statements and IPO documents have been inaccurate and materially misleading throughout the IPO period. When the market learned the truth about Zhangmen, investors suffered damage.

Join the case to make up for your losses.

The law firm Schall represents investors worldwide and specializes in securities class actions and shareholder disputes.

This press release may be viewed as a solicitation in some jurisdictions under applicable law and ethical rules.

Comments are closed.